UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

The New England journal of medicine, 2021-05, Vol.384 (20), p.1964-1965

2021

Link zum Volltext

Verfügbarkeit prüfen

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Journal of thrombosis and haemostasis, 2020-02, Vol.18 (2), p.411-421

2020

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants

Clinical and Applied Thrombosis/Hemostasis, 2017-07, Vol.23 (5), p.410-415

2017

Link zum Volltext

Verfügbarkeit prüfen

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants

Advances in hematology, 2020, Vol.2020, p.1-10

2020

Link zum Volltext

Verfügbarkeit prüfen

Averting a terminal transplant cascade

Blood, 2024-03, Vol.143 (12), p.1059

2024

Link zum Volltext

Verfügbarkeit prüfen

An Algorithmic Approach to Management of Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis, 2017-09, Vol.23 (6), p.511-517

2017

Link zum Volltext

Verfügbarkeit prüfen

Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety

Research and practice in thrombosis and haemostasis, 2022-07, Vol.6 (5), p.e12781-n/a, Article e12781

2022

Link zum Volltext

Verfügbarkeit prüfen

S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE‐CEL), A FAST‐OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B‐CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY

HemaSphere, 2023-08, Vol.7 (S3), p.e998506d-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation

Case reports in genetics, 2022-03, Vol.2022, p.6977041-5

2022

Link zum Volltext

Verfügbarkeit prüfen

Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia

Therapeutic Advances in Hematology, 2016-06, Vol.7 (3), p.131-141

2016

Link zum Volltext

Verfügbarkeit prüfen

The different faces of disseminated intravascular coagulation in solid tumors: how to identify and manage

Oncology (Williston Park, N.Y.), 2015-02, Vol.29 (2), p.104, 106-104

Gundabolu, Krishna

2015

Link zum Volltext

Verfügbarkeit prüfen

Retroperitoneal hemorrhage following a bone marrow biopsy

Blood, 2021-10, Vol.138 (14), p.1283-1283

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Dose-Escalation Study of the Oral Epichaperome Inhibitor, Zelavespib (ZEL) in Combination with Ruxolitinib (RUX), in Patients with Relapsed Myelofibrosis: Results of the Dose Escalation Stage

Blood, 2022-11, Vol.140 (Supplement 1), p.6821-6822

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Insurance Types and Survival in Acute Promyelocytic Leukemia (APL)

Blood, 2021-11, Vol.138 (Supplement 1), p.4129-4129

2021

Link zum Volltext

Verfügbarkeit prüfen

Poor Outcomes of Older Adults with Acute Promyelocytic Leukemia (APL) Regardless of Insurance Types

Blood, 2021-11, Vol.138 (Supplement 1), p.3065-3065

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?

Leukemia & lymphoma, 2020-01, Vol.61 (1), p.7-17

2020

Link zum Volltext

Verfügbarkeit prüfen

Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia

Leukemia research, 2022-11, Vol.122, p.106927-106927, Article 106927

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Mortality and Overall Survival in Acute Promyelocytic Leukemia: Do Real-World Data Match Results of the Clinical Trials?

Blood, 2020-11, Vol.136 (Supplement 1), p.13-14

2020

Link zum Volltext

Verfügbarkeit prüfen

Age-Based Probability of Ten-Year Overall Survival (OS) of Acute Myeloid Leukemia (AML): A National Cancer Database (NCDB) Analysis

Blood, 2020-11, Vol.136 (Supplement 1), p.24-25

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Patients with Budd-Chiari Syndrome and Factors Predicting the Need for TIPS & Liver Transplantation - a Single-Center Long-Term Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.2123-2123

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Blood, 2015-12, Vol.126 (23), p.4668-4668

2015

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of Charlson comorbidity index (CCI) to predict early mortality and overall survival (OS) in acute myeloid leukemia (AML)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19129-e19129

2020

Link zum Volltext

Verfügbarkeit prüfen

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Blood, 2017-12, Vol.130, p.5013-5013

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Blood, 2017-12, Vol.130, p.4917-4917

2017

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL)

Blood, 2017-12, Vol.130, p.3431-3431

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(115)
Berichte
(3)

Sprache

Englisch
(118)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Humans
(40)
Hematology
(37)
Oncology
(25)
Aged
(17)
Female
(16)
Male
(15)
Middle Aged
(12)
Aged, 80 And Over
(9)
Prognosis
(9)
Acute Myeloid Leukemia
(8)
Chemotherapy
(8)
Adult
(7)
Leukemia
(7)
Leukemia, Myeloid, Acute - Drug Therapy
(7)
Leukemia, Myeloid, Acute - Mortality
(7)
Retrospective Studies
(7)
Treatment Outcome
(7)
Comorbidity
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants

Averting a terminal transplant cascade

An Algorithmic Approach to Management of Venous Thromboembolism

Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety

S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE‐CEL), A FAST‐OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B‐CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation

Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia

The different faces of disseminated intravascular coagulation in solid tumors: how to identify and manage

Retroperitoneal hemorrhage following a bone marrow biopsy

A Phase 1 Dose-Escalation Study of the Oral Epichaperome Inhibitor, Zelavespib (ZEL) in Combination with Ruxolitinib (RUX), in Patients with Relapsed Myelofibrosis: Results of the Dose Escalation Stage

Association of Insurance Types and Survival in Acute Promyelocytic Leukemia (APL)

Poor Outcomes of Older Adults with Acute Promyelocytic Leukemia (APL) Regardless of Insurance Types

Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?

Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia

Early Mortality and Overall Survival in Acute Promyelocytic Leukemia: Do Real-World Data Match Results of the Clinical Trials?

Age-Based Probability of Ten-Year Overall Survival (OS) of Acute Myeloid Leukemia (AML): A National Cancer Database (NCDB) Analysis

Outcomes of Patients with Budd-Chiari Syndrome and Factors Predicting the Need for TIPS & Liver Transplantation - a Single-Center Long-Term Experience

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Usefulness of Charlson comorbidity index (CCI) to predict early mortality and overall survival (OS) in acute myeloid leukemia (AML)

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL)

Suchergebnisse filtern